MAA
ARNA

Managed Account Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Managed Account Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$1K Buy
+31
New +$1.34K ﹤0.01% 3001

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Managed Account Advisors's ARNA Position: Q2 2015 in Review

Managed Account Advisors opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q2 2015: 31 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #3001 among its holdings.

130 funds tracked by Wall St. Rank hold ARNA as of Q2 2015.

  • Managed Account Advisors held 31 shares of Arena Pharmaceuticals Inc worth $1K as of Q2 2015.
  • Arena Pharmaceuticals Inc was a new Managed Account Advisors position in Q2 2015.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #3001 holding.
  • 130 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.